Dupilumab
4 NDCs across 1 manufacturer|0 Generic,4 Brand
Dupilumab is used to treat atopic dermatitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $2.5 billion on Dupilumab across 621,000 claims for 88,000 beneficiaries.
Dupilumab is available as 4 NDCs from 1 manufacturer (0 generic, 4 brand), with NADAC prices from $1009.16 to $1778.28 per ML — a 76% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
4
0G / 4B
Manufacturers
1
competing in market
Price Spread
$1009.16 – $1778.28
per ML
7d Activity
avg +0.0% WoW · of 4 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing DUPILUMAB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
DUPIXENT 200 MG/1.14 ML PEN | $1778.2754 per ML | -0.03% |
DUPIXENT 200 MG/1.14 ML SYRING | $1773.2433 per ML | +0.18% |
DUPIXENT 300 MG/2 ML SYRINGE | $1011.3804 per ML | +0.02% |
DUPIXENT 300 MG/2 ML PEN | $1009.1638 per ML | -0.02% |
Frequently Asked Questions
What is Dupilumab used to treat?
Dupilumab is used to treat atopic dermatitis, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Dupilumab?
In 2024, Medicare Part D spent $2.5 billion on Dupilumab across 621,000 claims for 88,000 beneficiaries.
How many Dupilumab products are on the market?
The Dupilumab drug market contains 4 NDCs from 1 manufacturer — 0 generic and 4 brand products.
What is the price range for Dupilumab?
NADAC reference prices for Dupilumab range from $1009.1638 to $1778.2754 per ML — a 76% difference between cheapest and most expensive.
Which manufacturers make Dupilumab?
1 manufacturer lists Dupilumab in NADAC. Ranked by number of NDCs, the largest are Sanofi-Aventis U.S. LLC (4).
How has the price of Dupilumab changed recently?
Over the past 7 days, 2 Dupilumab NDCs rose and 2 fell, with a market-wide average change of +0.0%.